Capsaicinoids supplementation decreases percent body fat and fat mass: adjustment using covariates in a post hoc analysis View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-08-13

AUTHORS

James Rogers, Stacie L. Urbina, Lem W. Taylor, Colin D. Wilborn, Martin Purpura, Ralf Jäger, Vijaya Juturu

ABSTRACT

BackgroundCapsaicinoids (CAPs) found in chili peppers and pepper extracts, are responsible for enhanced metabolism. The objective of the study was to evaluate the effects of CAPs on body fat and fat mass while considering interactions with body habitus, diet and metabolic propensity.MethodsSeventy-five (N = 75) volunteer (male and female, age: 18 and 56 years) healthy subjects were recruited. This is a parallel group, randomized, double-blind, placebo controlled exploratory study. Subjects were randomly assigned to receive either placebo, 2 mg CAPs or 4 mg CAPs dosing for 12 weeks. After initial screening, subjects were evaluated with respect to fat mass and percent body fat at baseline and immediately following a 12-week treatment period. The current study evaluates two measures of fat loss while considering six baseline variables related to fat loss. Baseline measurements of importance in this paper are those used to evaluate body habitus, diet, and metabolic propensity. Lean mass and fat mass (body habitus); protein intake, fat intake and carbohydrate intake; and total serum cholesterol level (metabolic propensity) were assessed. Body fat and fat mass were respectively re-expressed as percent change in body fat and change in fat mass by application of formula outcome = (12-week value – baseline value) / baseline value) × 100. Thus, percent change in body fat and change in fat mass served as dependent variables in the evaluation of CAPs. Inferential statistical tests were derived from the model to compare low dose CAPs to placebo and high dose CAPs to placebo.ResultsPercent change in body fat after 12 weeks of treatment was 5.91 percentage units lower in CAPs 4 mg subjects than placebo subjects after adjustment for covariates (p = 0.0402). Percent change in fat mass after 12 weeks of treatment was 6.68 percentage units lower in Caps 4 mg subjects than placebo subjects after adjustment for covariates (p = 0.0487).ConclusionThese results suggest potential benefits of Capsaicinoids (CAPs) on body fat and fat mass in post hoc analysis. Further studies are required to explore pharmacological, physiological, and metabolic benefits of both chronic and acute Capsaicinoids consumption.Trial registrationISRCTN10458693 ‘retrospectively registered’. More... »

PAGES

22

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s40608-018-0197-1

DOI

http://dx.doi.org/10.1186/s40608-018-0197-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1104414263

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30123516


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Summit Analytical, LLC, 8354 Northfield Blvd., Building G, Suite 3700, 80238, Denver, CO, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Summit Analytical, LLC, 8354 Northfield Blvd., Building G, Suite 3700, 80238, Denver, CO, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rogers", 
        "givenName": "James", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Human Performance Laboratory, University of Mary Hardin-Baylor, 76513, Belton, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.441596.b", 
          "name": [
            "Human Performance Laboratory, University of Mary Hardin-Baylor, 76513, Belton, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Urbina", 
        "givenName": "Stacie L.", 
        "id": "sg:person.014331177577.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014331177577.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Human Performance Laboratory, University of Mary Hardin-Baylor, 76513, Belton, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.441596.b", 
          "name": [
            "Human Performance Laboratory, University of Mary Hardin-Baylor, 76513, Belton, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Taylor", 
        "givenName": "Lem W.", 
        "id": "sg:person.01122644701.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122644701.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Human Performance Laboratory, University of Mary Hardin-Baylor, 76513, Belton, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.441596.b", 
          "name": [
            "Human Performance Laboratory, University of Mary Hardin-Baylor, 76513, Belton, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wilborn", 
        "givenName": "Colin D.", 
        "id": "sg:person.0631520440.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631520440.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Increnovo LLC, 2138 E Lafayette Pl, 53202, Milwaukee, WI, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Increnovo LLC, 2138 E Lafayette Pl, 53202, Milwaukee, WI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Purpura", 
        "givenName": "Martin", 
        "id": "sg:person.0647320012.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647320012.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Increnovo LLC, 2138 E Lafayette Pl, 53202, Milwaukee, WI, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Increnovo LLC, 2138 E Lafayette Pl, 53202, Milwaukee, WI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "J\u00e4ger", 
        "givenName": "Ralf", 
        "id": "sg:person.01165612516.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165612516.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "OmniActive Health Technologies Inc., 67 East Park Place, Suite 500, 07950, Morristown, NJ, USA", 
          "id": "http://www.grid.ac/institutes/grid.487313.a", 
          "name": [
            "OmniActive Health Technologies Inc., 67 East Park Place, Suite 500, 07950, Morristown, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Juturu", 
        "givenName": "Vijaya", 
        "id": "sg:person.01315535723.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315535723.27"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/s12933-015-0183-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036581480", 
          "https://doi.org/10.1186/s12933-015-0183-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.ijo.0802862", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034525454", 
          "https://doi.org/10.1038/sj.ijo.0802862"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1476-511x-9-72", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041771130", 
          "https://doi.org/10.1186/1476-511x-9-72"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.ijo.0803351", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004157543", 
          "https://doi.org/10.1038/sj.ijo.0803351"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4612-1344-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052867188", 
          "https://doi.org/10.1007/978-1-4612-1344-4"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-08-13", 
    "datePublishedReg": "2018-08-13", 
    "description": "BackgroundCapsaicinoids (CAPs) found in chili peppers and pepper extracts, are responsible for enhanced metabolism. The objective of the study was to evaluate the effects of CAPs on body fat and fat mass while considering interactions with body habitus, diet and metabolic propensity.MethodsSeventy-five (N\u2009=\u200975) volunteer (male and female, age: 18 and 56\u00a0years) healthy subjects were recruited. This is a parallel group, randomized, double-blind, placebo controlled exploratory study. Subjects were randomly assigned to receive either placebo, 2\u00a0mg CAPs or 4\u00a0mg CAPs dosing for 12\u00a0weeks. After initial screening, subjects were evaluated with respect to fat mass and percent body fat at baseline and immediately following a 12-week treatment period. The current study evaluates two measures of fat loss while considering six baseline variables related to fat loss. Baseline measurements of importance in this paper are those used to evaluate body habitus, diet, and metabolic propensity. Lean mass and fat mass (body habitus); protein intake, fat intake and carbohydrate intake; and total serum cholesterol level (metabolic propensity) were assessed. Body fat and fat mass were respectively re-expressed as percent change in body fat and change in fat mass by application of formula outcome\u2009=\u2009(12-week value \u2013 baseline value) / baseline value) \u00d7\u2009100. Thus, percent change in body fat and change in fat mass served as dependent variables in the evaluation of CAPs. Inferential statistical tests were derived from the model to compare low dose CAPs to placebo and high dose CAPs to placebo.ResultsPercent change in body fat after 12\u00a0weeks of treatment was 5.91 percentage units lower in CAPs 4\u00a0mg subjects than placebo subjects after adjustment for covariates (p\u2009=\u20090.0402). Percent change in fat mass after 12\u00a0weeks of treatment was 6.68 percentage units lower in Caps 4\u00a0mg subjects than placebo subjects after adjustment for covariates (p\u2009=\u20090.0487).ConclusionThese results suggest potential benefits of Capsaicinoids (CAPs) on body fat and fat mass in post hoc analysis. Further studies are required to explore pharmacological, physiological, and metabolic benefits of both chronic and acute Capsaicinoids consumption.Trial registrationISRCTN10458693 \u2018retrospectively registered\u2019.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s40608-018-0197-1", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1050619", 
        "issn": [
          "2052-9538"
        ], 
        "name": "BMC Obesity", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "5"
      }
    ], 
    "keywords": [
      "weeks of treatment", 
      "fat mass", 
      "body fat", 
      "percent body fat", 
      "percent change", 
      "placebo subjects", 
      "body habitus", 
      "fat loss", 
      "total serum cholesterol levels", 
      "volunteer healthy subjects", 
      "serum cholesterol levels", 
      "effects of capsaicinoids", 
      "fat intake", 
      "baseline variables", 
      "parallel group", 
      "carbohydrate intake", 
      "cholesterol levels", 
      "metabolic propensity", 
      "treatment period", 
      "metabolic benefits", 
      "healthy subjects", 
      "baseline values", 
      "protein intake", 
      "baseline measurements", 
      "placebo", 
      "ConclusionThese results", 
      "enhanced metabolism", 
      "intake", 
      "weeks", 
      "inferential statistical tests", 
      "Further studies", 
      "fat", 
      "initial screening", 
      "subjects", 
      "covariates", 
      "diet", 
      "treatment", 
      "current study", 
      "pepper extract", 
      "potential benefits", 
      "adjustment", 
      "study", 
      "percentage units", 
      "baseline", 
      "outcomes", 
      "exploratory study", 
      "chili pepper", 
      "changes", 
      "dependent variable", 
      "metabolism", 
      "capsaicinoids", 
      "screening", 
      "benefits", 
      "mass", 
      "loss", 
      "statistical tests", 
      "group", 
      "cap 4", 
      "propensity", 
      "extract", 
      "period", 
      "levels", 
      "evaluation", 
      "variables", 
      "units", 
      "measures", 
      "test", 
      "effect", 
      "analysis", 
      "objective", 
      "habitus", 
      "consumption", 
      "importance", 
      "results", 
      "values", 
      "pepper", 
      "measurements", 
      "interaction", 
      "model", 
      "respect", 
      "applications", 
      "paper"
    ], 
    "name": "Capsaicinoids supplementation decreases percent body fat and fat mass: adjustment using covariates in a post hoc analysis", 
    "pagination": "22", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1104414263"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s40608-018-0197-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30123516"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s40608-018-0197-1", 
      "https://app.dimensions.ai/details/publication/pub.1104414263"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:34", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_772.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s40608-018-0197-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s40608-018-0197-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s40608-018-0197-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s40608-018-0197-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s40608-018-0197-1'


 

This table displays all metadata directly associated to this object as RDF triples.

212 TRIPLES      22 PREDICATES      113 URIs      100 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s40608-018-0197-1 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author Ne10ed4989c904379bc4258ce59ed907a
4 schema:citation sg:pub.10.1007/978-1-4612-1344-4
5 sg:pub.10.1038/sj.ijo.0802862
6 sg:pub.10.1038/sj.ijo.0803351
7 sg:pub.10.1186/1476-511x-9-72
8 sg:pub.10.1186/s12933-015-0183-6
9 schema:datePublished 2018-08-13
10 schema:datePublishedReg 2018-08-13
11 schema:description BackgroundCapsaicinoids (CAPs) found in chili peppers and pepper extracts, are responsible for enhanced metabolism. The objective of the study was to evaluate the effects of CAPs on body fat and fat mass while considering interactions with body habitus, diet and metabolic propensity.MethodsSeventy-five (N = 75) volunteer (male and female, age: 18 and 56 years) healthy subjects were recruited. This is a parallel group, randomized, double-blind, placebo controlled exploratory study. Subjects were randomly assigned to receive either placebo, 2 mg CAPs or 4 mg CAPs dosing for 12 weeks. After initial screening, subjects were evaluated with respect to fat mass and percent body fat at baseline and immediately following a 12-week treatment period. The current study evaluates two measures of fat loss while considering six baseline variables related to fat loss. Baseline measurements of importance in this paper are those used to evaluate body habitus, diet, and metabolic propensity. Lean mass and fat mass (body habitus); protein intake, fat intake and carbohydrate intake; and total serum cholesterol level (metabolic propensity) were assessed. Body fat and fat mass were respectively re-expressed as percent change in body fat and change in fat mass by application of formula outcome = (12-week value – baseline value) / baseline value) × 100. Thus, percent change in body fat and change in fat mass served as dependent variables in the evaluation of CAPs. Inferential statistical tests were derived from the model to compare low dose CAPs to placebo and high dose CAPs to placebo.ResultsPercent change in body fat after 12 weeks of treatment was 5.91 percentage units lower in CAPs 4 mg subjects than placebo subjects after adjustment for covariates (p = 0.0402). Percent change in fat mass after 12 weeks of treatment was 6.68 percentage units lower in Caps 4 mg subjects than placebo subjects after adjustment for covariates (p = 0.0487).ConclusionThese results suggest potential benefits of Capsaicinoids (CAPs) on body fat and fat mass in post hoc analysis. Further studies are required to explore pharmacological, physiological, and metabolic benefits of both chronic and acute Capsaicinoids consumption.Trial registrationISRCTN10458693 ‘retrospectively registered’.
12 schema:genre article
13 schema:inLanguage en
14 schema:isAccessibleForFree true
15 schema:isPartOf N208c8cea70174a5ebd2eed0faf77d617
16 Nba4d367b1ba84d159acaea0d581c87b8
17 sg:journal.1050619
18 schema:keywords ConclusionThese results
19 Further studies
20 adjustment
21 analysis
22 applications
23 baseline
24 baseline measurements
25 baseline values
26 baseline variables
27 benefits
28 body fat
29 body habitus
30 cap 4
31 capsaicinoids
32 carbohydrate intake
33 changes
34 chili pepper
35 cholesterol levels
36 consumption
37 covariates
38 current study
39 dependent variable
40 diet
41 effect
42 effects of capsaicinoids
43 enhanced metabolism
44 evaluation
45 exploratory study
46 extract
47 fat
48 fat intake
49 fat loss
50 fat mass
51 group
52 habitus
53 healthy subjects
54 importance
55 inferential statistical tests
56 initial screening
57 intake
58 interaction
59 levels
60 loss
61 mass
62 measurements
63 measures
64 metabolic benefits
65 metabolic propensity
66 metabolism
67 model
68 objective
69 outcomes
70 paper
71 parallel group
72 pepper
73 pepper extract
74 percent body fat
75 percent change
76 percentage units
77 period
78 placebo
79 placebo subjects
80 potential benefits
81 propensity
82 protein intake
83 respect
84 results
85 screening
86 serum cholesterol levels
87 statistical tests
88 study
89 subjects
90 test
91 total serum cholesterol levels
92 treatment
93 treatment period
94 units
95 values
96 variables
97 volunteer healthy subjects
98 weeks
99 weeks of treatment
100 schema:name Capsaicinoids supplementation decreases percent body fat and fat mass: adjustment using covariates in a post hoc analysis
101 schema:pagination 22
102 schema:productId Nc23e96a3e4b146409c6ba30e1effde08
103 Ne6aab6f3eb024385a032de2f9d3da2e3
104 Ne810bb89dd6d48799c9c1b3ed9c79228
105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104414263
106 https://doi.org/10.1186/s40608-018-0197-1
107 schema:sdDatePublished 2022-05-20T07:34
108 schema:sdLicense https://scigraph.springernature.com/explorer/license/
109 schema:sdPublisher N602549c54e1d4a478877fae66a2a7e1a
110 schema:url https://doi.org/10.1186/s40608-018-0197-1
111 sgo:license sg:explorer/license/
112 sgo:sdDataset articles
113 rdf:type schema:ScholarlyArticle
114 N208c8cea70174a5ebd2eed0faf77d617 schema:issueNumber 1
115 rdf:type schema:PublicationIssue
116 N20d3bb35d463492e916c608aa983245c rdf:first sg:person.01165612516.84
117 rdf:rest Nf4e72541f1cc4f80bac9ee328a4db20b
118 N3c7a494c15e644679546a13d544be574 rdf:first sg:person.0631520440.77
119 rdf:rest Nab2cf794e78644d086334ad256e898ed
120 N602549c54e1d4a478877fae66a2a7e1a schema:name Springer Nature - SN SciGraph project
121 rdf:type schema:Organization
122 N605e84dcaf334bb39ebced7b62230490 rdf:first sg:person.01122644701.21
123 rdf:rest N3c7a494c15e644679546a13d544be574
124 Nab2cf794e78644d086334ad256e898ed rdf:first sg:person.0647320012.70
125 rdf:rest N20d3bb35d463492e916c608aa983245c
126 Nba4d367b1ba84d159acaea0d581c87b8 schema:volumeNumber 5
127 rdf:type schema:PublicationVolume
128 Nc23e96a3e4b146409c6ba30e1effde08 schema:name doi
129 schema:value 10.1186/s40608-018-0197-1
130 rdf:type schema:PropertyValue
131 Ncc84d3ad441144538170c80d41f65c31 rdf:first sg:person.014331177577.38
132 rdf:rest N605e84dcaf334bb39ebced7b62230490
133 Ndd526d5c6b524c79a019e5beab458a74 schema:affiliation grid-institutes:None
134 schema:familyName Rogers
135 schema:givenName James
136 rdf:type schema:Person
137 Ne10ed4989c904379bc4258ce59ed907a rdf:first Ndd526d5c6b524c79a019e5beab458a74
138 rdf:rest Ncc84d3ad441144538170c80d41f65c31
139 Ne6aab6f3eb024385a032de2f9d3da2e3 schema:name pubmed_id
140 schema:value 30123516
141 rdf:type schema:PropertyValue
142 Ne810bb89dd6d48799c9c1b3ed9c79228 schema:name dimensions_id
143 schema:value pub.1104414263
144 rdf:type schema:PropertyValue
145 Nf4e72541f1cc4f80bac9ee328a4db20b rdf:first sg:person.01315535723.27
146 rdf:rest rdf:nil
147 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
148 schema:name Medical and Health Sciences
149 rdf:type schema:DefinedTerm
150 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
151 schema:name Clinical Sciences
152 rdf:type schema:DefinedTerm
153 sg:journal.1050619 schema:issn 2052-9538
154 schema:name BMC Obesity
155 schema:publisher Springer Nature
156 rdf:type schema:Periodical
157 sg:person.01122644701.21 schema:affiliation grid-institutes:grid.441596.b
158 schema:familyName Taylor
159 schema:givenName Lem W.
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122644701.21
161 rdf:type schema:Person
162 sg:person.01165612516.84 schema:affiliation grid-institutes:None
163 schema:familyName Jäger
164 schema:givenName Ralf
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165612516.84
166 rdf:type schema:Person
167 sg:person.01315535723.27 schema:affiliation grid-institutes:grid.487313.a
168 schema:familyName Juturu
169 schema:givenName Vijaya
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315535723.27
171 rdf:type schema:Person
172 sg:person.014331177577.38 schema:affiliation grid-institutes:grid.441596.b
173 schema:familyName Urbina
174 schema:givenName Stacie L.
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014331177577.38
176 rdf:type schema:Person
177 sg:person.0631520440.77 schema:affiliation grid-institutes:grid.441596.b
178 schema:familyName Wilborn
179 schema:givenName Colin D.
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631520440.77
181 rdf:type schema:Person
182 sg:person.0647320012.70 schema:affiliation grid-institutes:None
183 schema:familyName Purpura
184 schema:givenName Martin
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647320012.70
186 rdf:type schema:Person
187 sg:pub.10.1007/978-1-4612-1344-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052867188
188 https://doi.org/10.1007/978-1-4612-1344-4
189 rdf:type schema:CreativeWork
190 sg:pub.10.1038/sj.ijo.0802862 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034525454
191 https://doi.org/10.1038/sj.ijo.0802862
192 rdf:type schema:CreativeWork
193 sg:pub.10.1038/sj.ijo.0803351 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004157543
194 https://doi.org/10.1038/sj.ijo.0803351
195 rdf:type schema:CreativeWork
196 sg:pub.10.1186/1476-511x-9-72 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041771130
197 https://doi.org/10.1186/1476-511x-9-72
198 rdf:type schema:CreativeWork
199 sg:pub.10.1186/s12933-015-0183-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036581480
200 https://doi.org/10.1186/s12933-015-0183-6
201 rdf:type schema:CreativeWork
202 grid-institutes:None schema:alternateName Increnovo LLC, 2138 E Lafayette Pl, 53202, Milwaukee, WI, USA
203 Summit Analytical, LLC, 8354 Northfield Blvd., Building G, Suite 3700, 80238, Denver, CO, USA
204 schema:name Increnovo LLC, 2138 E Lafayette Pl, 53202, Milwaukee, WI, USA
205 Summit Analytical, LLC, 8354 Northfield Blvd., Building G, Suite 3700, 80238, Denver, CO, USA
206 rdf:type schema:Organization
207 grid-institutes:grid.441596.b schema:alternateName Human Performance Laboratory, University of Mary Hardin-Baylor, 76513, Belton, TX, USA
208 schema:name Human Performance Laboratory, University of Mary Hardin-Baylor, 76513, Belton, TX, USA
209 rdf:type schema:Organization
210 grid-institutes:grid.487313.a schema:alternateName OmniActive Health Technologies Inc., 67 East Park Place, Suite 500, 07950, Morristown, NJ, USA
211 schema:name OmniActive Health Technologies Inc., 67 East Park Place, Suite 500, 07950, Morristown, NJ, USA
212 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...